FindTrial
Sign In

Effect of argatroban on the Basal Vein drainage in Acute Ischemic Stroke

Effect of argatroban on the Basal Vein drainage in Acute Ischemic Stroke

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IPR-16008663
Enrollment
Unknown
Registered
2016-06-17
Start date
2016-06-17
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ischemic stroke

Interventions

control group:standard treatment
argatroban group :argatroban treatment

Sponsors

Tianjin Medical University General Hospital Medical Ethics Committee
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 70 years; 2. Acute ischemic stroke: All patients had symptoms of focal neurological deficits and simultaneous radiological evidence (magnetic resonance imaging, MRI) of an ventricular ischemic brain lesion; 3. measurable neurological deficit (NIHSS >=5); 4. interval between symptom onset and admission more than 6 hours and less than 48 hours.

Exclusion criteria

Exclusion criteria: 1. hemorrhagic stroke and severe hemorrhage in other organs; 2. other diseases of the central nervous system (CNS); 3. diabetes mellitus; 4. tumor or hematological systemic diseases; 5. any infection before acute ischemic stroke; 6. contraindication to MRI and TCD.

Design outcomes

Primary

MeasureTime frame
Mean Flow Velocities in the Basal Vein;NIHSS score;Barthel Index;mRS score;—

Countries

China

Contacts

Public ContactJunwei Hao

Tianjin Medical University General Hospital

jhao0216@gmail.com+86 13902168652

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026